# The Reactivity of 2-Ethoxy-4-Chloroquinazoline and Its Use in Synthesis of Novel Quinazoline Derivatives

Authors: M. A. El-Hashash; K. M. Darwish; S. A. Rizk; F. A. El-Bassiouny
Journal: Organic Chemistry International
 (2011)

---

## Abstract

The behavior of 2-ethoxy-4-chloroquinazoline2 towards various nitrogen nucleophiles, namely: thiosemicarbazide, sodium azide, glucosamine, ethanol, and hydrazine hydrate has been discussed. Also, the behavior of 4-(2-ethoxyquinazolin-4-yl)thiosemicarbazide towards one-carbon, for example, ethyl chloroformate, and two-carbon donors, for example, ethyl chloroacetate and diethyl oxalate has been investigated. On the other hand, new 5-ethoxy-2-substituted[1,2,4]-triazolo-[1,5-c]quinazoline derivatives have been obtained by ring closure accompanied with Dimroth rearrangement through the interaction of compound 2 with hydrazides of acetic, benzoic, crotonic, cinnamic, 2-furoic, and phthalimidoacetic acids. Structures of the novel products were confirmed by elemental, IR, MS, and 1H-NMR spectral analyses.


---

## Body

## 1. Introduction

Quinazolines are a big family of heterocyclic compounds, which have shown broad variety of biological activity profiles [1, 2], for example, analgesic, narcotic, diuretic, antihypertensive, antimalarial, sedative, hypoglycaemic, antibiotic, antitumoral, and many others. It has been found [3] that the biological activity strongly depends on the type and place of the substituents in their molecules.Out of the wide substitution patterns known, 4-aminoquinazolines are useful as fungicides [4, 5], anti-inflammatory [6, 7], anticancer [8, 9], antimicrobial, and antihypertensive agents [10, 11]. Some 4-anilinoquinazolines have been found to be potential and highly selective inhibitors of human immunoglobulin E [12] and epidermal growth factor receptor tyrosine kinase [13] which regulates the cell growth and proliferation, so they can work as potent antiallergic or anticancer agents, respectively. Among the broad synthetic pathways for aminoquinazoline preparation [14, 15] the substitution of chlorine atom in 4-chloroquinazolines by amines is the shortest and cheapest one. On the other hand, it is well known that heterocycle-bearing N-glycosides play a significant role as inhibitors, for example, the tetrazole-bearing N-glycosides used as SGLT2 inhibitors [16] where their hypoglycemic activity is tested in vivoby mice oral glucose tolerance test (OGTT). In the current paper we report the synthesis of 4-aminoquinazoline-bearing N-glycosides in a similar way, with exception of the endocyclic 2° nitrogen atom attached to the glucose moiety.


## 2. Results and Discussion

In many syntheses of quinazoline derivatives the 4-chloroquinazoline exhibits a very important key intermediate due to its reactivity towards many types of nucleophiles, especially the nitrogen and oxygen nucleophiles [17–19]. The stepwise synthesis of 4-chloro-2-ethoxyquinazoline 2 starts with aminolysis of 2-ethoxy(4H)-3,1-benzoxazin-4-one affording 2-ethoxy-4(3H)quinazolinone1 followed by the chlorination by phosphorus oxychloride in boiling water bath (Scheme 1) [20–22].Scheme 1
Synthetic pathway for compound2.Compound2interacted with thiosemicarbazide in boiling acetic acid affording the open-chain intermediate 3which was reacted, as a good substrate for one-carbon and two-carbon donors, with ethyl chloroformate, diethyl oxalate, and ethyl chloroacetate giving open products that cyclized, in turn, affording the new 4-triazolo- and 4-triazinoquinazoline products 4−6, respectively (Scheme 2).Scheme 2
Synthetic pathway for compounds4–6.Treatment of compound2 with sodium azide in acetic acid (Scheme 3) gave derivative 7 whose analogues are believed to have antimicrobial and anti-inflammatory activities [23–25].Scheme 3
Synthetic pathway for compound7.Glucosamine is one of the constituents of chitin, chitosan, and mucopolysaccharides and has important biomedical applications, including pharmaceutical preparations for treating cartilage diseases of joints [26–30]. Such preparations include often glucosamine hydrochloride or sulfate and chondroitin sulfate. In this paper we invented reaction of the 4-chloroquinazoline 2 with glucosamine hydrochloride in the presence of sodium bicarbonate in methanol to afford product 8 (α and β anomers) (Scheme 4). Structures of  8(α + β) were assigned by TLC and 1H-NMR spectra. The 1H-NMR spectra for 8(α + β) showed H-1 doublets at 5.05 and 4.80 ppm, characteristic for the α and β anomers, respectively [31]. Moreover, the TLC data obtained at room temperature including silica gel and a mixture of ethyl acetate : hexane (3 : 1) indicated that derivative 8 presented two spots, with Rf value for β anomer being double that for α.Scheme 4
Synthetic pathway for compound8 anomers.Recently, it was reported that 4-substituted-aminoquinazolines are exploited as potent antitumor compounds (human breast carcinoma cell line in which EGFR is highly expressed) [32]. Herein we synthesized 4-hydrazinoquinazoline 9 by reacting compound 2with hydrazine hydrate in boiling ethanol (Scheme 5). During the synthesis of product 9, variable quantities of derivatives 10and11were also obtained as shown by mass spectral data. Product 11, in its hydrochloride form, was obtained due to the reaction of derivative 2with absolute ethanol during synthesis of derivative 9.Scheme 5
Synthetic pathway for compounds9–11.Also, as a good substrate for one-carbon donors, product2reacted with acid hydrazides, namely: acetic, benzoic, crotonic, cinnamic, furoic, and phthalimidoacetic hydrazides affording first the 2-acylated-1-(2-ethoxyquinazolin-4-yl) hydrazine products which, on heating, rearranged giving the imidamide tautomer (Scheme 6) and then cyclized losing water to give the triazoloquinazolines 12a–f, respectively. Whereas the literature indicates the possibility for the Dimroth rearrangement [33], we have been unable to unambiguously verify the structures of 12, and the proposed structures are on the basis of mass spectral fragments observed.Scheme 6
Synthetic pathway for compounds12a–f.For each compound the mass spectrum showed a molecular ion peak for the parent compound and ion peaks for fragments, which showed no indication for molecular ion peaks to be attributed to nitrogen gas or aziridine residues in the 5-ethoxy-3-X[1,2,4]triazolo[4,3-c]quinazoline fragmentation but the fragments detected included the diazireno[1,3-c]quinazoline residue, confirming that a single nitrogen atom was lost in 5-ethoxy-2-methyl[1,2,4]triazolo[1,5-c]quinazoline fragmentation.


## 3. Experimental

All melting points recorded are uncorrected. The IR spectra were recorded on a Pye Unicam SP 1200 spectrophotometer using KBr wafer technique. The1H-NMR spectra were determined on a Varian FT-200, Brucker AC-200 MHz spectrophotometry experiment using TMS as an internal standard. Chemical shifts (δ) are expressed in ppm. The mass spectra were determined using MP model NS-5988 and Shimadzu single focusing mass spectrometer (70 eV).The 2-ethoxy(4H)-3,1-benzoxazin-4-one was prepared according to methods available in the literature [34] and was immediately used after preparation, prior to each synthesis to avoid moisture.


### 3.1. 2-Ethoxy-4(3H)quinazolinone1

2-ethoxy(4H)-3,1-benzoxazin-4-one (0.01 mol) and ammonium acetate (0.01 mol) were fused using an oil bath for 2 h. The mixture was poured into an ice/water mixture and stirred. The beige white precipitate that separated out was filtered, washed, dried, and then crystallized from ethanol affording beige white crystals of quinazolinone 1. M.p. 155-156°C; yield 85%; Elemental analysis for C10H10N2O2 (M.wt. 190); Found: C, 63.16; H, 5.26; N, 14.74; Calcd: C, 63.22; H, 5.18; N, 14.72; IR υ (cm−1) 1671 (C=O), 3229 (NH); MS: m/z [M+H]+ 190 (58%); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3 of ethoxyJ =7.4 Hz), 4.29 (q, 2H; CH2 of ethoxy J = 7.4), 7.31–8.17 (4Xd, 4H; ArH), 12.30 (br s, 1H, NH).


### 3.2. 4-Chloro-2-ethoxyquinazoline2

A mixture of 2-Ethoxy-4(3H)quinazolinone 1 (0.01 mol), phosphorus oxychloride (10 mL) was heated using water bath for 30 min. The excess oxychloride was removed under reduced pressure, and crushed ice (20 g) was added to the residue. The separated solid was filtered, washed with water, dried, and crystallized from chloroform affording the product 2; yield 64%; m.p. 180–182°C. Anal.for C10H9N2OCl (M.wt. 208.5); Found: C, 57.45; H, 4.31; N, 13.42; Cl, 17.00; Calcd: C, 57.55; H, 4.3; N, 13.43; Cl, 17.02; IR υ (cm−1) 1622 (C=N); MS: m/z [M+H]+ 208.5; 1H-NMR (DMSO-d6) δ 1.17 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of ethoxy J = 7.4), 7.13–8.28 (4d, 4H, ArH).


### 3.3. 4-(2-Ethoxyquinazolin-4-yl)thiosemicarbazide3

Refluxing a mixture of the quinazoline2and thiosemicarbazide (0.01 mol each) in acetic acid/fused sodium acetate (30 mL/2 g) for 3 h and pouring the solution onto ice/water left a white solid. The latter was filtered, washed with water, dried, and crystallized from ethanol affording white crystals of compound 3; yield 74%; m.p. 128–130°C. Anal.for C11H13N5OS (M.wt. 263); Found: C, 53.38; H, 5.19; N, 28.39; Calcd: C, 53.44; H, 5.26; N, 28.34; IR υ (cm−1) 1381 (C=S), 1620 (C=N), 3418, 3250 (NH and NH2). MS: m/z [M+H]+ 263 (77%). 1H-NMR (DMSO-d6) δ 1.20 (t, 3H; CH3 of ethoxy J = 7.2 Hz), 4.15 (q, 2H; CH2 of ethoxy J = 7.2), 7.44–8.06 (4d, 4H, ArH), 8.41–9.34 (2 br. s, 4H, 2 NH and NH2).


### 3.4. 5-Ethoxy-1-(2-ethoxyquinazolin-4-yl)-1,2-dihydro-3H-1,2,4-triazole-3-thione4

Quinazolinone3(0.01 mol) was heated under reflux with ethyl chloroformate (0.01 mol) in dry pyridine (30 mL) for 3 h. The excess solvent was removed by distillation, and the solution was left to cool down and then poured into an ice/HCl mixture with stirring to obtain the crude product which was filtered off, thoroughly washed with cold water, dried, and crystallized from ethanol affording product 4; brown crystals (m.p. 239–241°C). Yield 67%; Anal. for C14H15N5O2S (M.wt. 317); Found: C, 52.81; H, 4.51; N, 22.22; Calcd: C, 52.99; H, 4.73; N, 22.08; IR υ (cm−1) 1273 (C=S), 1619 (C=N), 2992 (CH), 3314 (sec NH); MS: m/z [M+H]+ 317; 1H-NMR (DMSO-d6) δ 1.23 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 1.19 (t, 3H, CH3 of ethoxy of triazole), 4.16 (q, 2H, CH2 of ethoxy J = 7.4 Hz), 4.41 (q, 2H, CH2 of ethoxy of triazole), 7.55–8.83 (m, 4H, ArH), 7.83 (br, 1H, NH), and 8.34 (br, 1H, NH).


### 3.5. 1-(2-Ethoxyquinazolin-4-yl)-3-thioxo-1,2,4-triazinane-5,6-dione5

A mixture of compound3(0.01 mol) and diethyl oxalate (0.01 mol) in absolute ethanol (20 mL) was heated under reflux for 2 h. The excess ethanol was distilled-off, and the separated solid was dried and crystallized from ethanol affording white crystals of product 5; yield 78%; m.p. 228–230°C. Anal. for C13H11N5O3S (M.wt. 317); Found: C, 49.08; H, 3.56; N, 22.01; Calcd: C, 49.21; H, 3.47; N, 22.08; IR υ (cm−1) 1319 (C=S), 1622 (C=N), 1640 (C=O), 3316 (sec NH); MS: m/z [M+H]+ 317 (72%). 1H-NMR (DMSO-d6) δ 1.27 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of ethoxy J = 7.4), 7.54–8.83 (4Xd, 4H, ArH), 7.62 (br, 1H, NH), and 8.13 (br, 1H, NH).


### 3.6. 1-(2-ethoxyquinazolin-4-yl)-3-thioxo-1,2,4-triazinan-5-one6

A mixture of3(0.01 mol) and ethyl chloroacetate (0.01 mol) in absolute ethanol (25 mL) was heated under reflux for 10 h. The solid that separated after cooling and crystallization from dioxane gave 6; brown crystals (m.p. 196–199°C). Yield 66%. Anal. for C13H13N5O2S (M.wt. 303); Found: C, 51.44; H, 4.14; N, 23.02; S, 10.78; Calcd: C, 51.49; H, 4.29; N, 23.10; S, 10.56; IR υ (cm−1) 1276 (C=S), 1622 (C=N), 1671 (C=O), 2990 (CH), 3316 (sec NH); MS: m/z [M+H]+ 303; 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.08, 4.31 (2 d, 2H, CH2CO), 4.15 (q, 2H, CH2 of ethoxy J = 7.4), 7.43–7.87 (m, 4H, ArH), 7.82 (br, 1H, NH), and 8.35 (br. s, 1H, NH).


### 3.7. 5-Ethoxy-s-tetrazolo-[1,5-c]quinazoline7

A mixture of quinazoline2(0.01 mol) and sodium azide (0.01 mol) in acetic acid (15 mL) was heated under reflux for 2 h. The solvent was evaporated under vacuum, and the separated solid was filtered, washed with water, dried, and recrystallized from ethanol affording off-white needles of compound 7 (m.p. 168–170°C). Yield 63%. Anal.for C10H9N5O (M.wt. 215); Found: C, 55.76; H, 4.14; N, 32.62; Calcd: C, 55.81; H, 4.18; N, 32.56; IR υ (cm−1) 1622 (C=N); MS: m/z [M+H]+ 215; 1H-NMR (DMSO-d6) δ 1.16 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.31 (q, 2H, CH2 of ethoxy J = 7.4), 7.55–8.53 (4d, 4H, ArH).


### 3.8. 2-[N-(2-Ethoxyquinazolin-4-yl]-2-deoxy-D-glucose8(α+β)

A mixture of compound2and glucosamine hydrochloride (0.01 mol each) in methanol/sodium bicarbonate mixture (20 mL/0.025 mol) was stirred at 50°C for 12 h. The reaction mixture was filtered, washed, and dried affording a white solid. Purification was performed using column chromatography (3 : 1, EtOAc : Hexane), and the resultant white solid was later on recrystallized using dichloromethane, diethyl ether, hexane solvents affording the crystalline products 8(α+β).


### 3.9. Anomer8α

Yield 14%.Anal. for C16H21N3O6(M.wt. 351); Found: C, 55.21; H, 6.01; N, 11.92; Calcd: C, 54.70; H, 5.98; N, 11.96; IR υ (cm−1) 1622 (C=N); 2852, 2922 (CH, CH2); 3315 (OH); MS: m/z [M+H]+ 351; 1H-NMR (DMSO-d6) δ 1.20 (t, 3H; CH3 of ethoxy J = 6.8 Hz), 3.22–3.91 (m, 6H; H-2′, H-3′, H-4′, H-5′, H-6′a, and H-6′b), 3.71 (m, 1′-OH, 3′-OH, 4′-OH), 4.13 (q, 2H; CH2 of ethoxy J = 6.8), 5.05 (d, 1H; H-1′, J = 6.5), 4.92 (s, 6′-OH), 7.41–7.85 (m, 4H; ArH); 9.38 (bs, 1H, NH).


### 3.10. Anomer8β

Yield 18%.Anal. for C16H21N3O6(M.wt. 351); Found: C, 55.92; H, 5.93; N, 11.98; Calcd: C, 54.70; H, 5.98; N, 11.96; IR υ (cm−1) 1619 (C=N); 2871, 2918 (CH, CH2); 3341 (OH); MS: m/z [M+H]+ 351; 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3 of ethoxy J = 6.8 Hz), 3.19–3.92 (m, 6H; H-2′, H-3′, H-4′, H-5′, H-6′a, and H-6′b), 3.76 (m, 1′-OH, 3′-OH, 4′-OH), 4.15 (q, 2H; CH2 of ethoxy J = 6.8 Hz), 4.80 (d, 1H; H-1′, J = 6.5), 4.88 (s, 6′-OH), 7.41–7.85 (m, 4H; ArH); 9.42 (bs, 1H, NH).


### 3.11. Reaction of 4-chloro-2-ethoxyquinazoline2 with hydrazine

An emulsion of product2 (0.01 mol) and hydrazine hydrate (0.05 mol) in benzene (15 mL) was stirred for 2 h. The benzene-insoluble gum obtained was treated and washed with water, dried, and recrystallized from ethanol giving reddish brown crystals of product 9. Evaporation of solvent, from the benzene-soluble fraction gave a residue that was rinsed with water and dried. Recrystallization of the residue from absolute ethanol gave a mixture containing product 10according to mass spectrum. Evaporation of the ethanolic mother liquor, extraction of the resulting residue with chloroform, evaporation of solvent and treatment of the residue with ether afforded product 11 as hydrochloride. The presence of halogen was verified by a green flame with a copper wire.


#### 3.11.1. 2-Ethoxyquinazolin-4-ylhydrazine9

Yield 68%; m.p. 156–158°C.Anal. for C10H12N4O (M.wt. 204); Found: C, 58.86; H, 5.78; N, 27.45; Calcd: C, 58.82; H, 5.88; N, 27.45; IR υ (cm−1) 1620 (C=N), 3160 (NH), 3250, 3300 (NH2); MS: m/z [M+H]+ 204; 1H-NMR (DMSO-d6) δ 1.18 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.17 (q, 2H, CH2 of ethoxy J = 7.4), 7.40– 8.06 (m, 4H, ArH), 8.65 (br. s, 3H, NH and NH2).


#### 3.11.2. (4Z,4′Z)-4,4′-(1Z,2Z)-hydrazine-1,2-diylidenebis(2-ethoxy-3,4-dihydroquinazoline)10

Yield 24%; m.p. 204–206°C.Anal. for C20H20N6O2 (M.wt. 376); Found: C, 86.84; H, 5.26; N, 22.26; Calcd: C, 86.96; H, 5.32; N, 22.34; IR υ (cm−1) 1635 (C=N), 3160 (NH); MS: m/z [M+H]+ 376; 1H-NMR (DMSO-d6) δ 1.17 (t, 6H, 2CH3 of 2 ethoxy J = 7.4 Hz), 4.44–4.54 (q, 4H, 2 CH2 of 2 ethoxy J = 7.4), 7.18–7.71 (m, 8H, ArH), 9.65 (br. s, 2H, 2NH).


#### 3.11.3. 2,4-Diethoxyquinazoline hydrochloride11

Yield 42%; m.p. 181-182°C.Anal.for C12H15ClN2O2 (M.wt. 254.5); Found: C, 56.62; H, 5.96; Cl, 14.51; N, 9.88; Calcd: C, 56.58; H, 5.89; N, 9.82; Cl, 14.46; IR υ (cm−1) 1619 (C=N); MS: m/z [M+H]+ 254.5; 1H-NMR (DMSO-d6) δ 1.14 (t, 3H, CH3 of 4-ethoxy J = 7.4 Hz), 1.20 (t, 3H, CH3 of 2-ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of 2-ethoxy J = 7.4), 4.22 (q, 2H, CH2 of 4-ethoxy J = 7.4), 7.53–8.82 (m, 4H, ArH).


### 3.12. General Procedure for the Synthesis of Compounds12a–f

A mixture of equimolar amounts of compound2and the acid hydrazides namely: acetic, benzoic, crotonic, cinnamic, furoic, and phthalimidoacetic hydrazides (0.01 mol) was heated on an oil bath for 3 h (6 h in the case of phthalimidoacetic hydrazides). The precipitate that separated out was filtered, washed, dried, and then crystallized from ethanol affording crystals 12a–f, respectively.


#### 3.12.1. 5-ethoxy-2-methyl[1,2,4]triazolo[1,5-c]quinazoline12a

Colorless needles from ethanol. Yield 58%; m.p. 158–160°C.Anal.for C12H12N4O (M.wt. 228); Found: C, 63.28; H, 5.32; N, 24.64; Calcd: C, 63.16; H, 5.26; N, 24.56; IR υ (cm−1) 1619 (C=N), 2992 (CH); MS: m/z [M+H]+ 228 (78.3), 230 (12.3), 215 (61.9), 217 (9.2), 203 (43.7), 205 (2.4), 188 (1.6), 190 (0.5), 143 (100), 145 (0.2), 130 (0.2), 132 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 2.52 (s, 3H, CH3), 4.27 (q, 2H, CH2 of 2-ethoxy J = 7.4), 7.48–8.02 (m, 4H, ArH).


#### 3.12.2. 5-ethoxy-2-phenyl [1,2,4]triazolo[1,5-c]quinazoline12b

Colorless needles from ethanol; m.p. 168−170°C; yield 68%.Anal.for C17H14N4O (M. wt. 290); Found: C, 70.17; H, 4.91; N, 19.38; Calcd: C, 70.34; H, 4.83; N, 19.31; IR υ (cm−1) 1622 (C=N), 3050 (CH); MS: m/z [M+H]+ 290 (32.2), 292 (12.3), 215 (100), 217 (23.5), 203 (12.1), 205 (6.4), 188 (18.5), 190 (9.2), 143 (83.8), 145 (8.2), 130 (3.1), 132 (0.1), 77 (13.2), 79 (0.3); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H, CH3 of ethoxy J = 7.4), 4.35 (q, 2H, CH2 of ethoxy J = 7.4), 7.55–8.08 (m, 5H, phenyl), 7.65–8.62 (4d, 4H, ArH).


#### 3.12.3. 5-ethoxy-2-[(1E)-prop-1-en-1-yl][1,2,4]triazolo[1,5-c]quinazoline12c

Brownish white crystals from ethanol; m.p. 223–225°C; yield 71%.Anal.for C14H14N4O (M.wt. 254); Found: C, 66.28; H, 5.31; N, 22.23; Calcd: C, 66.14; H, 5.51; N, 22.05; IR υ (cm−1) 1635 (C=N), 3050 (CH); MS: m/z [M+H]+ 254 (48.2), 256 (14.2), 215 (100), 217 (29.5), 203 (22.2), 205 (9.5), 188 (16.9), 190 (6.3), 143 (88.6), 145 (38.1), 130 (4.5), 132 (0.1); 1H-NMR (DMSO-d6) δ 1.21 (t, 3H, CH3 of ethoxy J = 7.4), 1.67 (t, 3H, CH3), 4.31 (q, 2H, CH2 of ethoxy J = 7.4), 6.10, 6.70 (2d, 2H, 2CHtrans), 7.53–8.21 (m, 4H, ArH).


#### 3.12.4. 5-ethoxy-2-[(E)-2-phenylethenyl][1,2,4]triazolo[1,5-c]quinazoline12d

Brownish white crystals from ethanol; 153–155°C; yield 62%.Anal.for C19H16N4O (M.wt. 316); Found: C, 72.84; H, 5.19; N, 17.76; Calcd: C, 72.15; H, 5.06; N, 17.72; IR υ (cm−1) 1633 (C=N); MS: m/z [M+H]+ 316 (29.3), 318 (12.8), 215 (100), 217 (21.8), 203 (19.3), 205 (8.7), 188 (13.7), 190 (4.3), 143 (67.3), 145 (18.3), 130 (2.5), 132 (0.1), 104 (1.1), 106 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4), 4.36 (q, 2H, CH2 of ethoxy J = 7.4), 7.09 (d, 1H, CHtrans), 7.47 (d, 1H, CHtrans), 7.39−7.60 (m, 5H, Ph-H), 7.47–8.63 (m, 4H, ArH).


#### 3.12.5. 5-ethoxy-2-(furan-2-yl)[1,2,4]triazolo[1,5-c]quinazoline12e

White crystals from benzene; 163-164°C; yield 68%.Anal.for C15H12N4O2 (M.wt. 280); Found: C, 64.38; H, 4.31; N, 20.07; Calcd: C, 64.29; H, 4.29; N, 20.00; IR υ (cm−1) 1619 (C=N), MS: m/z [M+H]+ 280 (33.2), 282 (12.4), 215 (100), 217 (29.5), 203 (21.3), 205 (11.3), 188 (16.9), 190 (6.3), 143 (88.6), 145 (38.1), 130 (4.5), 132 (0.1), 68 (1.2), 70 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.29 (q, 2H, CH2 of ethoxy J = 7.4), 6.76 (q, 1H, J = 3.6 Hz, J = 1.6, Furan-H), 7.43 (q, 1H, J = 4.4, Furan-H), 7.85 (q, 1H, J = 1.6 Hz, Furan-H), 7.54–8.02 (m, 4H, ArH).


#### 3.12.6. 2-[(5-ethoxy[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl]-1H-isoindole-1,3(2H)-dione12f

Brown crystals from DMF; m.p. 286–288°C; yield 72%.Anal.for C20H15N5O3 (M.wt. 373); found: C, 58.72; H, 3.66; N, 16.31; Calcd: C, 58.20; H, 3.46; N, 16.17; IR υ (cm−1) 1631 (C=N), 1727, 1776 (2C=O). MS: m/z [M+H]+ 373 (58.0), 375 (31.2), 215 (44.1), 217 (27.8), 203 (24.5), 205 (13.6), 188 (26.1), 190 (16.2), 161 (33.3), 163 (21.1), 147 (18.7), 149 (9.8), 143 (11.1), 145 (6.2), 130 (0.6), 132 (0.2), 122 (2.2), 124 (1.1), 78 (0.2), 80 (0.1); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3of ethoxy J = 7.1), 4.37 (q, 2H; CH2 of ethoxy), 5.55 (s, 2H; CH2, phthalimidomethyl), 7.55–8.03 (m, 4H, quinazol.), 7.73–7.87 (m, 4H, phthalimido moiety).


## 3.1. 2-Ethoxy-4(3H)quinazolinone1

2-ethoxy(4H)-3,1-benzoxazin-4-one (0.01 mol) and ammonium acetate (0.01 mol) were fused using an oil bath for 2 h. The mixture was poured into an ice/water mixture and stirred. The beige white precipitate that separated out was filtered, washed, dried, and then crystallized from ethanol affording beige white crystals of quinazolinone 1. M.p. 155-156°C; yield 85%; Elemental analysis for C10H10N2O2 (M.wt. 190); Found: C, 63.16; H, 5.26; N, 14.74; Calcd: C, 63.22; H, 5.18; N, 14.72; IR υ (cm−1) 1671 (C=O), 3229 (NH); MS: m/z [M+H]+ 190 (58%); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3 of ethoxyJ =7.4 Hz), 4.29 (q, 2H; CH2 of ethoxy J = 7.4), 7.31–8.17 (4Xd, 4H; ArH), 12.30 (br s, 1H, NH).


## 3.2. 4-Chloro-2-ethoxyquinazoline2

A mixture of 2-Ethoxy-4(3H)quinazolinone 1 (0.01 mol), phosphorus oxychloride (10 mL) was heated using water bath for 30 min. The excess oxychloride was removed under reduced pressure, and crushed ice (20 g) was added to the residue. The separated solid was filtered, washed with water, dried, and crystallized from chloroform affording the product 2; yield 64%; m.p. 180–182°C. Anal.for C10H9N2OCl (M.wt. 208.5); Found: C, 57.45; H, 4.31; N, 13.42; Cl, 17.00; Calcd: C, 57.55; H, 4.3; N, 13.43; Cl, 17.02; IR υ (cm−1) 1622 (C=N); MS: m/z [M+H]+ 208.5; 1H-NMR (DMSO-d6) δ 1.17 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of ethoxy J = 7.4), 7.13–8.28 (4d, 4H, ArH).


## 3.3. 4-(2-Ethoxyquinazolin-4-yl)thiosemicarbazide3

Refluxing a mixture of the quinazoline2and thiosemicarbazide (0.01 mol each) in acetic acid/fused sodium acetate (30 mL/2 g) for 3 h and pouring the solution onto ice/water left a white solid. The latter was filtered, washed with water, dried, and crystallized from ethanol affording white crystals of compound 3; yield 74%; m.p. 128–130°C. Anal.for C11H13N5OS (M.wt. 263); Found: C, 53.38; H, 5.19; N, 28.39; Calcd: C, 53.44; H, 5.26; N, 28.34; IR υ (cm−1) 1381 (C=S), 1620 (C=N), 3418, 3250 (NH and NH2). MS: m/z [M+H]+ 263 (77%). 1H-NMR (DMSO-d6) δ 1.20 (t, 3H; CH3 of ethoxy J = 7.2 Hz), 4.15 (q, 2H; CH2 of ethoxy J = 7.2), 7.44–8.06 (4d, 4H, ArH), 8.41–9.34 (2 br. s, 4H, 2 NH and NH2).


## 3.4. 5-Ethoxy-1-(2-ethoxyquinazolin-4-yl)-1,2-dihydro-3H-1,2,4-triazole-3-thione4

Quinazolinone3(0.01 mol) was heated under reflux with ethyl chloroformate (0.01 mol) in dry pyridine (30 mL) for 3 h. The excess solvent was removed by distillation, and the solution was left to cool down and then poured into an ice/HCl mixture with stirring to obtain the crude product which was filtered off, thoroughly washed with cold water, dried, and crystallized from ethanol affording product 4; brown crystals (m.p. 239–241°C). Yield 67%; Anal. for C14H15N5O2S (M.wt. 317); Found: C, 52.81; H, 4.51; N, 22.22; Calcd: C, 52.99; H, 4.73; N, 22.08; IR υ (cm−1) 1273 (C=S), 1619 (C=N), 2992 (CH), 3314 (sec NH); MS: m/z [M+H]+ 317; 1H-NMR (DMSO-d6) δ 1.23 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 1.19 (t, 3H, CH3 of ethoxy of triazole), 4.16 (q, 2H, CH2 of ethoxy J = 7.4 Hz), 4.41 (q, 2H, CH2 of ethoxy of triazole), 7.55–8.83 (m, 4H, ArH), 7.83 (br, 1H, NH), and 8.34 (br, 1H, NH).


## 3.5. 1-(2-Ethoxyquinazolin-4-yl)-3-thioxo-1,2,4-triazinane-5,6-dione5

A mixture of compound3(0.01 mol) and diethyl oxalate (0.01 mol) in absolute ethanol (20 mL) was heated under reflux for 2 h. The excess ethanol was distilled-off, and the separated solid was dried and crystallized from ethanol affording white crystals of product 5; yield 78%; m.p. 228–230°C. Anal. for C13H11N5O3S (M.wt. 317); Found: C, 49.08; H, 3.56; N, 22.01; Calcd: C, 49.21; H, 3.47; N, 22.08; IR υ (cm−1) 1319 (C=S), 1622 (C=N), 1640 (C=O), 3316 (sec NH); MS: m/z [M+H]+ 317 (72%). 1H-NMR (DMSO-d6) δ 1.27 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of ethoxy J = 7.4), 7.54–8.83 (4Xd, 4H, ArH), 7.62 (br, 1H, NH), and 8.13 (br, 1H, NH).


## 3.6. 1-(2-ethoxyquinazolin-4-yl)-3-thioxo-1,2,4-triazinan-5-one6

A mixture of3(0.01 mol) and ethyl chloroacetate (0.01 mol) in absolute ethanol (25 mL) was heated under reflux for 10 h. The solid that separated after cooling and crystallization from dioxane gave 6; brown crystals (m.p. 196–199°C). Yield 66%. Anal. for C13H13N5O2S (M.wt. 303); Found: C, 51.44; H, 4.14; N, 23.02; S, 10.78; Calcd: C, 51.49; H, 4.29; N, 23.10; S, 10.56; IR υ (cm−1) 1276 (C=S), 1622 (C=N), 1671 (C=O), 2990 (CH), 3316 (sec NH); MS: m/z [M+H]+ 303; 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.08, 4.31 (2 d, 2H, CH2CO), 4.15 (q, 2H, CH2 of ethoxy J = 7.4), 7.43–7.87 (m, 4H, ArH), 7.82 (br, 1H, NH), and 8.35 (br. s, 1H, NH).


## 3.7. 5-Ethoxy-s-tetrazolo-[1,5-c]quinazoline7

A mixture of quinazoline2(0.01 mol) and sodium azide (0.01 mol) in acetic acid (15 mL) was heated under reflux for 2 h. The solvent was evaporated under vacuum, and the separated solid was filtered, washed with water, dried, and recrystallized from ethanol affording off-white needles of compound 7 (m.p. 168–170°C). Yield 63%. Anal.for C10H9N5O (M.wt. 215); Found: C, 55.76; H, 4.14; N, 32.62; Calcd: C, 55.81; H, 4.18; N, 32.56; IR υ (cm−1) 1622 (C=N); MS: m/z [M+H]+ 215; 1H-NMR (DMSO-d6) δ 1.16 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.31 (q, 2H, CH2 of ethoxy J = 7.4), 7.55–8.53 (4d, 4H, ArH).


## 3.8. 2-[N-(2-Ethoxyquinazolin-4-yl]-2-deoxy-D-glucose8(α+β)

A mixture of compound2and glucosamine hydrochloride (0.01 mol each) in methanol/sodium bicarbonate mixture (20 mL/0.025 mol) was stirred at 50°C for 12 h. The reaction mixture was filtered, washed, and dried affording a white solid. Purification was performed using column chromatography (3 : 1, EtOAc : Hexane), and the resultant white solid was later on recrystallized using dichloromethane, diethyl ether, hexane solvents affording the crystalline products 8(α+β).


## 3.9. Anomer8α

Yield 14%.Anal. for C16H21N3O6(M.wt. 351); Found: C, 55.21; H, 6.01; N, 11.92; Calcd: C, 54.70; H, 5.98; N, 11.96; IR υ (cm−1) 1622 (C=N); 2852, 2922 (CH, CH2); 3315 (OH); MS: m/z [M+H]+ 351; 1H-NMR (DMSO-d6) δ 1.20 (t, 3H; CH3 of ethoxy J = 6.8 Hz), 3.22–3.91 (m, 6H; H-2′, H-3′, H-4′, H-5′, H-6′a, and H-6′b), 3.71 (m, 1′-OH, 3′-OH, 4′-OH), 4.13 (q, 2H; CH2 of ethoxy J = 6.8), 5.05 (d, 1H; H-1′, J = 6.5), 4.92 (s, 6′-OH), 7.41–7.85 (m, 4H; ArH); 9.38 (bs, 1H, NH).


## 3.10. Anomer8β

Yield 18%.Anal. for C16H21N3O6(M.wt. 351); Found: C, 55.92; H, 5.93; N, 11.98; Calcd: C, 54.70; H, 5.98; N, 11.96; IR υ (cm−1) 1619 (C=N); 2871, 2918 (CH, CH2); 3341 (OH); MS: m/z [M+H]+ 351; 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3 of ethoxy J = 6.8 Hz), 3.19–3.92 (m, 6H; H-2′, H-3′, H-4′, H-5′, H-6′a, and H-6′b), 3.76 (m, 1′-OH, 3′-OH, 4′-OH), 4.15 (q, 2H; CH2 of ethoxy J = 6.8 Hz), 4.80 (d, 1H; H-1′, J = 6.5), 4.88 (s, 6′-OH), 7.41–7.85 (m, 4H; ArH); 9.42 (bs, 1H, NH).


## 3.11. Reaction of 4-chloro-2-ethoxyquinazoline2 with hydrazine

An emulsion of product2 (0.01 mol) and hydrazine hydrate (0.05 mol) in benzene (15 mL) was stirred for 2 h. The benzene-insoluble gum obtained was treated and washed with water, dried, and recrystallized from ethanol giving reddish brown crystals of product 9. Evaporation of solvent, from the benzene-soluble fraction gave a residue that was rinsed with water and dried. Recrystallization of the residue from absolute ethanol gave a mixture containing product 10according to mass spectrum. Evaporation of the ethanolic mother liquor, extraction of the resulting residue with chloroform, evaporation of solvent and treatment of the residue with ether afforded product 11 as hydrochloride. The presence of halogen was verified by a green flame with a copper wire.


### 3.11.1. 2-Ethoxyquinazolin-4-ylhydrazine9

Yield 68%; m.p. 156–158°C.Anal. for C10H12N4O (M.wt. 204); Found: C, 58.86; H, 5.78; N, 27.45; Calcd: C, 58.82; H, 5.88; N, 27.45; IR υ (cm−1) 1620 (C=N), 3160 (NH), 3250, 3300 (NH2); MS: m/z [M+H]+ 204; 1H-NMR (DMSO-d6) δ 1.18 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.17 (q, 2H, CH2 of ethoxy J = 7.4), 7.40– 8.06 (m, 4H, ArH), 8.65 (br. s, 3H, NH and NH2).


### 3.11.2. (4Z,4′Z)-4,4′-(1Z,2Z)-hydrazine-1,2-diylidenebis(2-ethoxy-3,4-dihydroquinazoline)10

Yield 24%; m.p. 204–206°C.Anal. for C20H20N6O2 (M.wt. 376); Found: C, 86.84; H, 5.26; N, 22.26; Calcd: C, 86.96; H, 5.32; N, 22.34; IR υ (cm−1) 1635 (C=N), 3160 (NH); MS: m/z [M+H]+ 376; 1H-NMR (DMSO-d6) δ 1.17 (t, 6H, 2CH3 of 2 ethoxy J = 7.4 Hz), 4.44–4.54 (q, 4H, 2 CH2 of 2 ethoxy J = 7.4), 7.18–7.71 (m, 8H, ArH), 9.65 (br. s, 2H, 2NH).


### 3.11.3. 2,4-Diethoxyquinazoline hydrochloride11

Yield 42%; m.p. 181-182°C.Anal.for C12H15ClN2O2 (M.wt. 254.5); Found: C, 56.62; H, 5.96; Cl, 14.51; N, 9.88; Calcd: C, 56.58; H, 5.89; N, 9.82; Cl, 14.46; IR υ (cm−1) 1619 (C=N); MS: m/z [M+H]+ 254.5; 1H-NMR (DMSO-d6) δ 1.14 (t, 3H, CH3 of 4-ethoxy J = 7.4 Hz), 1.20 (t, 3H, CH3 of 2-ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of 2-ethoxy J = 7.4), 4.22 (q, 2H, CH2 of 4-ethoxy J = 7.4), 7.53–8.82 (m, 4H, ArH).


## 3.11.1. 2-Ethoxyquinazolin-4-ylhydrazine9

Yield 68%; m.p. 156–158°C.Anal. for C10H12N4O (M.wt. 204); Found: C, 58.86; H, 5.78; N, 27.45; Calcd: C, 58.82; H, 5.88; N, 27.45; IR υ (cm−1) 1620 (C=N), 3160 (NH), 3250, 3300 (NH2); MS: m/z [M+H]+ 204; 1H-NMR (DMSO-d6) δ 1.18 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.17 (q, 2H, CH2 of ethoxy J = 7.4), 7.40– 8.06 (m, 4H, ArH), 8.65 (br. s, 3H, NH and NH2).


## 3.11.2. (4Z,4′Z)-4,4′-(1Z,2Z)-hydrazine-1,2-diylidenebis(2-ethoxy-3,4-dihydroquinazoline)10

Yield 24%; m.p. 204–206°C.Anal. for C20H20N6O2 (M.wt. 376); Found: C, 86.84; H, 5.26; N, 22.26; Calcd: C, 86.96; H, 5.32; N, 22.34; IR υ (cm−1) 1635 (C=N), 3160 (NH); MS: m/z [M+H]+ 376; 1H-NMR (DMSO-d6) δ 1.17 (t, 6H, 2CH3 of 2 ethoxy J = 7.4 Hz), 4.44–4.54 (q, 4H, 2 CH2 of 2 ethoxy J = 7.4), 7.18–7.71 (m, 8H, ArH), 9.65 (br. s, 2H, 2NH).


## 3.11.3. 2,4-Diethoxyquinazoline hydrochloride11

Yield 42%; m.p. 181-182°C.Anal.for C12H15ClN2O2 (M.wt. 254.5); Found: C, 56.62; H, 5.96; Cl, 14.51; N, 9.88; Calcd: C, 56.58; H, 5.89; N, 9.82; Cl, 14.46; IR υ (cm−1) 1619 (C=N); MS: m/z [M+H]+ 254.5; 1H-NMR (DMSO-d6) δ 1.14 (t, 3H, CH3 of 4-ethoxy J = 7.4 Hz), 1.20 (t, 3H, CH3 of 2-ethoxy J = 7.4 Hz), 4.19 (q, 2H, CH2 of 2-ethoxy J = 7.4), 4.22 (q, 2H, CH2 of 4-ethoxy J = 7.4), 7.53–8.82 (m, 4H, ArH).


## 3.12. General Procedure for the Synthesis of Compounds12a–f

A mixture of equimolar amounts of compound2and the acid hydrazides namely: acetic, benzoic, crotonic, cinnamic, furoic, and phthalimidoacetic hydrazides (0.01 mol) was heated on an oil bath for 3 h (6 h in the case of phthalimidoacetic hydrazides). The precipitate that separated out was filtered, washed, dried, and then crystallized from ethanol affording crystals 12a–f, respectively.


### 3.12.1. 5-ethoxy-2-methyl[1,2,4]triazolo[1,5-c]quinazoline12a

Colorless needles from ethanol. Yield 58%; m.p. 158–160°C.Anal.for C12H12N4O (M.wt. 228); Found: C, 63.28; H, 5.32; N, 24.64; Calcd: C, 63.16; H, 5.26; N, 24.56; IR υ (cm−1) 1619 (C=N), 2992 (CH); MS: m/z [M+H]+ 228 (78.3), 230 (12.3), 215 (61.9), 217 (9.2), 203 (43.7), 205 (2.4), 188 (1.6), 190 (0.5), 143 (100), 145 (0.2), 130 (0.2), 132 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 2.52 (s, 3H, CH3), 4.27 (q, 2H, CH2 of 2-ethoxy J = 7.4), 7.48–8.02 (m, 4H, ArH).


### 3.12.2. 5-ethoxy-2-phenyl [1,2,4]triazolo[1,5-c]quinazoline12b

Colorless needles from ethanol; m.p. 168−170°C; yield 68%.Anal.for C17H14N4O (M. wt. 290); Found: C, 70.17; H, 4.91; N, 19.38; Calcd: C, 70.34; H, 4.83; N, 19.31; IR υ (cm−1) 1622 (C=N), 3050 (CH); MS: m/z [M+H]+ 290 (32.2), 292 (12.3), 215 (100), 217 (23.5), 203 (12.1), 205 (6.4), 188 (18.5), 190 (9.2), 143 (83.8), 145 (8.2), 130 (3.1), 132 (0.1), 77 (13.2), 79 (0.3); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H, CH3 of ethoxy J = 7.4), 4.35 (q, 2H, CH2 of ethoxy J = 7.4), 7.55–8.08 (m, 5H, phenyl), 7.65–8.62 (4d, 4H, ArH).


### 3.12.3. 5-ethoxy-2-[(1E)-prop-1-en-1-yl][1,2,4]triazolo[1,5-c]quinazoline12c

Brownish white crystals from ethanol; m.p. 223–225°C; yield 71%.Anal.for C14H14N4O (M.wt. 254); Found: C, 66.28; H, 5.31; N, 22.23; Calcd: C, 66.14; H, 5.51; N, 22.05; IR υ (cm−1) 1635 (C=N), 3050 (CH); MS: m/z [M+H]+ 254 (48.2), 256 (14.2), 215 (100), 217 (29.5), 203 (22.2), 205 (9.5), 188 (16.9), 190 (6.3), 143 (88.6), 145 (38.1), 130 (4.5), 132 (0.1); 1H-NMR (DMSO-d6) δ 1.21 (t, 3H, CH3 of ethoxy J = 7.4), 1.67 (t, 3H, CH3), 4.31 (q, 2H, CH2 of ethoxy J = 7.4), 6.10, 6.70 (2d, 2H, 2CHtrans), 7.53–8.21 (m, 4H, ArH).


### 3.12.4. 5-ethoxy-2-[(E)-2-phenylethenyl][1,2,4]triazolo[1,5-c]quinazoline12d

Brownish white crystals from ethanol; 153–155°C; yield 62%.Anal.for C19H16N4O (M.wt. 316); Found: C, 72.84; H, 5.19; N, 17.76; Calcd: C, 72.15; H, 5.06; N, 17.72; IR υ (cm−1) 1633 (C=N); MS: m/z [M+H]+ 316 (29.3), 318 (12.8), 215 (100), 217 (21.8), 203 (19.3), 205 (8.7), 188 (13.7), 190 (4.3), 143 (67.3), 145 (18.3), 130 (2.5), 132 (0.1), 104 (1.1), 106 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4), 4.36 (q, 2H, CH2 of ethoxy J = 7.4), 7.09 (d, 1H, CHtrans), 7.47 (d, 1H, CHtrans), 7.39−7.60 (m, 5H, Ph-H), 7.47–8.63 (m, 4H, ArH).


### 3.12.5. 5-ethoxy-2-(furan-2-yl)[1,2,4]triazolo[1,5-c]quinazoline12e

White crystals from benzene; 163-164°C; yield 68%.Anal.for C15H12N4O2 (M.wt. 280); Found: C, 64.38; H, 4.31; N, 20.07; Calcd: C, 64.29; H, 4.29; N, 20.00; IR υ (cm−1) 1619 (C=N), MS: m/z [M+H]+ 280 (33.2), 282 (12.4), 215 (100), 217 (29.5), 203 (21.3), 205 (11.3), 188 (16.9), 190 (6.3), 143 (88.6), 145 (38.1), 130 (4.5), 132 (0.1), 68 (1.2), 70 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.29 (q, 2H, CH2 of ethoxy J = 7.4), 6.76 (q, 1H, J = 3.6 Hz, J = 1.6, Furan-H), 7.43 (q, 1H, J = 4.4, Furan-H), 7.85 (q, 1H, J = 1.6 Hz, Furan-H), 7.54–8.02 (m, 4H, ArH).


### 3.12.6. 2-[(5-ethoxy[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl]-1H-isoindole-1,3(2H)-dione12f

Brown crystals from DMF; m.p. 286–288°C; yield 72%.Anal.for C20H15N5O3 (M.wt. 373); found: C, 58.72; H, 3.66; N, 16.31; Calcd: C, 58.20; H, 3.46; N, 16.17; IR υ (cm−1) 1631 (C=N), 1727, 1776 (2C=O). MS: m/z [M+H]+ 373 (58.0), 375 (31.2), 215 (44.1), 217 (27.8), 203 (24.5), 205 (13.6), 188 (26.1), 190 (16.2), 161 (33.3), 163 (21.1), 147 (18.7), 149 (9.8), 143 (11.1), 145 (6.2), 130 (0.6), 132 (0.2), 122 (2.2), 124 (1.1), 78 (0.2), 80 (0.1); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3of ethoxy J = 7.1), 4.37 (q, 2H; CH2 of ethoxy), 5.55 (s, 2H; CH2, phthalimidomethyl), 7.55–8.03 (m, 4H, quinazol.), 7.73–7.87 (m, 4H, phthalimido moiety).


## 3.12.1. 5-ethoxy-2-methyl[1,2,4]triazolo[1,5-c]quinazoline12a

Colorless needles from ethanol. Yield 58%; m.p. 158–160°C.Anal.for C12H12N4O (M.wt. 228); Found: C, 63.28; H, 5.32; N, 24.64; Calcd: C, 63.16; H, 5.26; N, 24.56; IR υ (cm−1) 1619 (C=N), 2992 (CH); MS: m/z [M+H]+ 228 (78.3), 230 (12.3), 215 (61.9), 217 (9.2), 203 (43.7), 205 (2.4), 188 (1.6), 190 (0.5), 143 (100), 145 (0.2), 130 (0.2), 132 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 2.52 (s, 3H, CH3), 4.27 (q, 2H, CH2 of 2-ethoxy J = 7.4), 7.48–8.02 (m, 4H, ArH).


## 3.12.2. 5-ethoxy-2-phenyl [1,2,4]triazolo[1,5-c]quinazoline12b

Colorless needles from ethanol; m.p. 168−170°C; yield 68%.Anal.for C17H14N4O (M. wt. 290); Found: C, 70.17; H, 4.91; N, 19.38; Calcd: C, 70.34; H, 4.83; N, 19.31; IR υ (cm−1) 1622 (C=N), 3050 (CH); MS: m/z [M+H]+ 290 (32.2), 292 (12.3), 215 (100), 217 (23.5), 203 (12.1), 205 (6.4), 188 (18.5), 190 (9.2), 143 (83.8), 145 (8.2), 130 (3.1), 132 (0.1), 77 (13.2), 79 (0.3); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H, CH3 of ethoxy J = 7.4), 4.35 (q, 2H, CH2 of ethoxy J = 7.4), 7.55–8.08 (m, 5H, phenyl), 7.65–8.62 (4d, 4H, ArH).


## 3.12.3. 5-ethoxy-2-[(1E)-prop-1-en-1-yl][1,2,4]triazolo[1,5-c]quinazoline12c

Brownish white crystals from ethanol; m.p. 223–225°C; yield 71%.Anal.for C14H14N4O (M.wt. 254); Found: C, 66.28; H, 5.31; N, 22.23; Calcd: C, 66.14; H, 5.51; N, 22.05; IR υ (cm−1) 1635 (C=N), 3050 (CH); MS: m/z [M+H]+ 254 (48.2), 256 (14.2), 215 (100), 217 (29.5), 203 (22.2), 205 (9.5), 188 (16.9), 190 (6.3), 143 (88.6), 145 (38.1), 130 (4.5), 132 (0.1); 1H-NMR (DMSO-d6) δ 1.21 (t, 3H, CH3 of ethoxy J = 7.4), 1.67 (t, 3H, CH3), 4.31 (q, 2H, CH2 of ethoxy J = 7.4), 6.10, 6.70 (2d, 2H, 2CHtrans), 7.53–8.21 (m, 4H, ArH).


## 3.12.4. 5-ethoxy-2-[(E)-2-phenylethenyl][1,2,4]triazolo[1,5-c]quinazoline12d

Brownish white crystals from ethanol; 153–155°C; yield 62%.Anal.for C19H16N4O (M.wt. 316); Found: C, 72.84; H, 5.19; N, 17.76; Calcd: C, 72.15; H, 5.06; N, 17.72; IR υ (cm−1) 1633 (C=N); MS: m/z [M+H]+ 316 (29.3), 318 (12.8), 215 (100), 217 (21.8), 203 (19.3), 205 (8.7), 188 (13.7), 190 (4.3), 143 (67.3), 145 (18.3), 130 (2.5), 132 (0.1), 104 (1.1), 106 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4), 4.36 (q, 2H, CH2 of ethoxy J = 7.4), 7.09 (d, 1H, CHtrans), 7.47 (d, 1H, CHtrans), 7.39−7.60 (m, 5H, Ph-H), 7.47–8.63 (m, 4H, ArH).


## 3.12.5. 5-ethoxy-2-(furan-2-yl)[1,2,4]triazolo[1,5-c]quinazoline12e

White crystals from benzene; 163-164°C; yield 68%.Anal.for C15H12N4O2 (M.wt. 280); Found: C, 64.38; H, 4.31; N, 20.07; Calcd: C, 64.29; H, 4.29; N, 20.00; IR υ (cm−1) 1619 (C=N), MS: m/z [M+H]+ 280 (33.2), 282 (12.4), 215 (100), 217 (29.5), 203 (21.3), 205 (11.3), 188 (16.9), 190 (6.3), 143 (88.6), 145 (38.1), 130 (4.5), 132 (0.1), 68 (1.2), 70 (0.1); 1H-NMR (DMSO-d6) δ 1.20 (t, 3H, CH3 of ethoxy J = 7.4 Hz), 4.29 (q, 2H, CH2 of ethoxy J = 7.4), 6.76 (q, 1H, J = 3.6 Hz, J = 1.6, Furan-H), 7.43 (q, 1H, J = 4.4, Furan-H), 7.85 (q, 1H, J = 1.6 Hz, Furan-H), 7.54–8.02 (m, 4H, ArH).


## 3.12.6. 2-[(5-ethoxy[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl]-1H-isoindole-1,3(2H)-dione12f

Brown crystals from DMF; m.p. 286–288°C; yield 72%.Anal.for C20H15N5O3 (M.wt. 373); found: C, 58.72; H, 3.66; N, 16.31; Calcd: C, 58.20; H, 3.46; N, 16.17; IR υ (cm−1) 1631 (C=N), 1727, 1776 (2C=O). MS: m/z [M+H]+ 373 (58.0), 375 (31.2), 215 (44.1), 217 (27.8), 203 (24.5), 205 (13.6), 188 (26.1), 190 (16.2), 161 (33.3), 163 (21.1), 147 (18.7), 149 (9.8), 143 (11.1), 145 (6.2), 130 (0.6), 132 (0.2), 122 (2.2), 124 (1.1), 78 (0.2), 80 (0.1); 1H-NMR (DMSO-d6) δ 1.19 (t, 3H; CH3of ethoxy J = 7.1), 4.37 (q, 2H; CH2 of ethoxy), 5.55 (s, 2H; CH2, phthalimidomethyl), 7.55–8.03 (m, 4H, quinazol.), 7.73–7.87 (m, 4H, phthalimido moiety).



---

*Source: 295491-2011-12-28.xml*